RÉSUMÉ
Background. Asphodelus tenuifolius Cav. (Asphodelaceae) is widely used in Pakistan traditional medicine as a hypotensive and diuretic agent. Despite the cardioprotective effects described for A. tenuifolius, the mechanisms involved in its probable hypotensive and diuretic effects have never been evaluated. Firstly, different extracts from A. tenuifolius seeds were obtained, and their antioxidant profiles and chemical constituents by LC-DAD-were determined, including molecular networking by the GNPS platform. Then, to evaluate changes in blood pressure, different groups of anesthetized normotensive rats were intravenously treated with the crude extract (AT-Cr, 1-50 mg/kg), aqueous (AS-AT, 1-25 mg/kg), n-butanol (BS-AT, 1-50 mg/kg), and dichloromethane fraction (DS-AT, 1-80 mg/kg). The diuretic effects of AT-Cr, AS-AT, BS-AT, and DS-AT at 100, 200, and 300 mg/kg, p.o. doses, were also evaluated in comparison with hydrochlorothiazide (HCTZ, 10 mg/kg, p.o). The urinary volume, sodium, potassium, and pH were estimated in the sample collected for 6 h from saline-loaded rats. Using pharmacological antagonists or inhibitors, we determine the involvement of acetylcholine, prostaglandins, and nitric oxide in A. tenuifolius-induced hypotensive and diuresis action. In addition, the activities of angiotensin-converting enzyme, erythrocyte carbonic anhydrase, and renal Na+/K+/ATPase were evaluated in vitro. Acute treatment with crude extract and fractions of A. tenuifolius exhibited significant hypotensive and diuretic potential in normotensive rats. However, AS-AT produced the most potent and significant dose-dependent hypotension and diuretic effects in normotensive rats. Previous treatment with atropine significantly reduced the hypotensive and diuretic action of AS-AT, but pretreatment with indomethacin or L-NAME did not affect these effects. Moreover, the 7-day treatment with AS-AT did not reduce activities of serum angiotensin-converting enzyme, erythrocyte carbonic anhydrase, and renal Na+/K+/ATPase. AS-AT showed four major compound node clusters, which included sugars, alkaloids, nucleoside, amino acid, and glycosylated flavonoids. This research supports and extends the traditional use of A. tenuifolius as a hypotensive and diuretic agent. The results showed that AS-AT from A. tenuifolius could present compounds responsible for hypotensive and diuretic activities through the activation of muscarinic receptors.
RÉSUMÉ
ETHNOPHARMACOLOGICAL RELEVANCE: Asphodelus tenuifolius Cav. (Asphodelaceae), a wild, terrestrial, annual stemless herb, is widely used in traditional medicine for the treatment of hypertension, diabetes, atherosclerosis and circulatory problems. A previous research study from our laboratory revealed that A. tenuifolius has beneficial effects in reducing blood pressure and improves aortic endothelial dysfunction in chronically glucose fed rats. Despite the fact that A. tenuifolius reduces blood pressure and improves endothelial function in vivo, there are no detailed studies about its possible mechanism of action. AIM OF THE STUDY: This study was designed to provide pharmacological basis and mechanism of action for the traditional use of A. tenuifolius in hypertension and circulatory problems. We explored the vasorelaxant effect of A. tenuifolius and its underlying vasorelaxation mechanism in porcine coronary artery rings. MATERIALS AND METHODS: Aqueous methanolic crude extract of A. tenuifolius was prepared by maceration process and then activity guided fractionation was carried out by using different polarity based solvents. Phytochemical studies were carried out using LC-DAD-MS. Segments of porcine distal coronary artery were set up in a wire myograph for isometric force measurements. Extract/fractions of A. tenuifolius seeds were tested for vasodilator activity by measurement of changes in tone after pre-contraction with the thromboxane mimetic U46619 in the presence or absence of inhibitors of intracellular signaling cascades. RESULTS: Crude extract/fractions of A. tenuifolius produced dose dependent endothelium independent vasorelaxant response in coronary rings, whereas, the butanol fraction of A. tenuifolius (BS-AT) produced the largest relaxation response with 100% relaxation at 1 mg/ml, therefore the mechanism of relaxation of this fraction was determined. The relaxation to BS-AT was unaffected by removal of the endothelium, pre-contraction with KCl, or the presence of the non-selective potassium channel blocker tetraethylammonium, indicating that the relaxation was endothelium-independent, and does not involve activation of potassium channels. BS-AT (1 mg/ml) inhibited the contractile response to calcium,the L-type calcium channel activator BAY K8664,and ionomycin, indicating that it inhibits calcium-induced contractions. The relaxation response to BS-AT was attenuated in the absence of extracellular calcium. However, relaxations to BS-AT were also reduced after deletion of calcium from intracellular stores with cyclopiazonic acid. Incubation with 1 mg/ml BS-AT also inhibited phosphorylation of myosin light chains in homogenates of coronary artery. CONCLUSION: The butanol extract of Asphodelus tenuifolius produces a large endothelium-independent relaxation of the porcine coronary artery through inhibition of calcium-induced contractions. The effect appears to be downstream of calcium influx, possibly through inhibition of myosin light chain kinase. This study supports previous studies demonstrating that A. tenuifolius reduces blood pressure. Future studies will aim to determine the active compounds underlying this response.
Sujet(s)
Asphodelaceae , Vaisseaux coronaires/effets des médicaments et des substances chimiques , Endothélium vasculaire/effets des médicaments et des substances chimiques , Myosin-Light-Chain Kinase/antagonistes et inhibiteurs , Extraits de plantes/pharmacologie , Vasodilatateurs/pharmacologie , Animaux , Vaisseaux coronaires/enzymologie , Relation dose-effet des médicaments , Endothélium vasculaire/enzymologie , Antienzymes/isolement et purification , Antienzymes/pharmacologie , Techniques de culture d'organes , Extraits de plantes/isolement et purification , Suidae , Vasodilatateurs/isolement et purificationRÉSUMÉ
ETHNO-PHARMACOLOGICAL RELEVANCE: Fruits of Crataegus songarica K. Koch. (Rosaceae) are commonly used in folk medicine for their diuretic properties to treat hypertension and congestive heart failure. To date, no scientific data has been published to support the diuretic potential. AIM OF THE STUDY: The purpose of this study was to evaluate efficacy and mechanism underlying the hypotensive and diuretic action of C. songarica in normotensive rats and to determine the constituents from the extracts by LC-DAD-MS. MATERIALS AND METHODS: Firstly, phytochemical profiling and antioxidant potential of C. songarica extracts was determined. Then, to evaluate changes in blood pressure, different groups of anesthetized normotensive rats were intravenously treated with crude extract (CS-Cr, 10-80 mg/kg), aqueous soluble (AS-CS, 0.1-20 mg/kg), and n-butanol soluble fractions of C. songarica (BS-CS, 1-80 mg/kg). The diuretic effects of CS-Cr (100-500 mg/kg, p.o), AS-CS (100-300 mg/kg, p.o) and BS-CS (100-300 mg/kg, p.o) were evaluated in comparison with hydrochlorothiazide (HCTZ, 10 mg/kg, p.o). The urinary volume, sodium, potassium and pH were estimated in the sample collected for 6 h from saline-loaded rats. Using pharmacological antagonists or inhibitors, we determine the involvement of acetylcholine, prostaglandins, and nitric oxide in C. songarica induced hypotensive and diuresis action. In addition, the activities of angiotensin converting enzyme, erythrocytary carbonic anhydrase and renal Na+/K+/ATPase were evaluated in vitro. RESULTS: From the LC-DAD-MS analyses, thirty-nine compounds were detected, showing a complex chemical profile and an expressive antioxidant activity "in vitro". Acute treatment with CS-Cr, AS-CS, and BS-CS exhibited significant hypotensive and diuretic potential in normotensive rats. However, AS-CS produced most potent and significant dose-dependent hypotension in normotensive rats, and also produced highly significant diuretic and saluretic effects. Despite the changes in urinary excretion of electrolytes, the plasmatic levels of sodium and potassium were not changed. Previous treatment with atropine and L-NAME significantly reduced the hypotensive and diuretic action of AS-CS in normotensive rats. Moreover, the 7-day treatment with AS-CS also resulted in significant ACE inhibitory activity. CONCLUSION: This research supports and extends the ethnomedicinal use of C. songarica as diuretic and hypotensive agent. The results showed that AS-CS from C. songarica could present compounds responsible for hypotensive and diuretic activities with no signs of toxicity, and these effects could involve nitric oxide pathway activated by muscarinic receptors or/and inhibition of angiotensin converting enzyme.
Sujet(s)
Antihypertenseurs/pharmacologie , Crataegus/composition chimique , Diurétiques/pharmacologie , Extraits de plantes/pharmacologie , Animaux , Antihypertenseurs/administration et posologie , Antihypertenseurs/isolement et purification , Pression sanguine/effets des médicaments et des substances chimiques , Chromatographie en phase liquide , GMP cyclique/métabolisme , Diurétiques/administration et posologie , Diurétiques/isolement et purification , Relation dose-effet des médicaments , Spectrométrie de masse , Monoxyde d'azote/métabolisme , Extraits de plantes/administration et posologie , Rats , Rat Sprague-Dawley , Système rénine-angiotensine/effets des médicaments et des substances chimiquesRÉSUMÉ
ETHNOPHARMACOLOGICAL RELEVANCE: Thymus linearis, Benth indigenous to Pakistan has been traditionally used for the treatment of various diseases including hypertension. AIM OF THE STUDY: Present study aims to investigate vasorelaxant effect of Thymus linearis and its underlying vasorelaxation mechanisms in porcine coronary artery rings. MATERIALS AND METHODS: Aqueous-methanolic extract of aerial parts of Thymus linearis was prepared by maceration process and then bio-guided fractionation was carried out using different solvents. The effects of extract and subsequent fractions were assessed on coronary artery rings with intact and denuded endothelium. The mechanisms of vasorelaxant effect were investigated using different pharmacological tools. The in-vitro inhibitory effects of the test fractions were also assessed on purified phophodiestrases using radioenzymatic assay. Phytochemical studies were carried out using GCMS. RESULTS: The aqueous-methanolic extract elicited similar relaxations in coronary artery rings with and without endothelium in dose dependent fashion and removal of endothelium did not alter this response. Further, n-butanolic fraction of Thymus liniaris (TLB) was found to be the most potent among other derived fractions. TLB did not alter the relaxation produced by endothelium dependent vasodilators in rings with intact endothelium. However, TLB significantly potentiated the relaxation elicited by cyclic AMP and cyclic GMP elevating drugs but not those to soluble guanylyl cyclase activators (YC-1 and BAY 41-2272) and K+ channel openers (levcromakalim and 1-EBIO). Pretreatment with TLB inhibited in a concentration-dependent manner contractions to KCl, CaCl2 and U46619 in coronary artery rings without endothelium. Further, TLB was found to non-selectively inhibit the PDE activity in concentration manner. CONCLUSION: n-Butanolic fraction of Thymus linearis possesses endothelium independent vasorelaxant effects in coronary artery by direct acting on the smooth muscles. These effects involve the elevation of the cyclic AMP and cyclic GMP possibly through the inhibition of various PDEs. GCMS analysis revel presence of thymole and carvacrol as major constituents. Furthermore, these investigations also support the folklore use of Thymus linearis in hypertension.
Sujet(s)
Vaisseaux coronaires/effets des médicaments et des substances chimiques , Extraits de plantes/pharmacologie , Thymus (plante) , Vasodilatateurs/pharmacologie , Butan-1-ol/composition chimique , Acétates/composition chimique , Animaux , Vaisseaux coronaires/physiologie , Endothélium vasculaire/effets des médicaments et des substances chimiques , Endothélium vasculaire/physiologie , Techniques in vitro , Méthanol/composition chimique , Parties aériennes de plante , Extraits de plantes/analyse , Polyphénols/analyse , Polyphénols/pharmacologie , Solvants/composition chimique , Suidae , Vasodilatation/effets des médicaments et des substances chimiques , Vasodilatateurs/analyseSujet(s)
Antihypertenseurs/usage thérapeutique , Asphodelaceae , Dyslipidémies/traitement médicamenteux , Hypertension artérielle/traitement médicamenteux , Syndrome métabolique X/traitement médicamenteux , Extraits de plantes/usage thérapeutique , Animaux , Dyslipidémies/induit chimiquement , Dyslipidémies/physiopathologie , Femelle , Glucose , Hypertension artérielle/induit chimiquement , Hypertension artérielle/physiopathologie , Insulinorésistance , Mâle , Syndrome métabolique X/induit chimiquement , Syndrome métabolique X/physiopathologie , Souris , Stress oxydatif/effets des médicaments et des substances chimiques , Rat Sprague-Dawley , Graines , Tests de toxicité aigüeRÉSUMÉ
BACKGROUND: Berberis orthobotrys Bien ex Aitch. (Berberidaceae) is a plant indigenous of Pakistan that is locally used for the treatment of hypertension. HYPOTHESIS: This study evaluated the vasoactive properties of a Berberis orthobotrys root extract and its fractions, and investigated the role of the endothelium and the underlying mechanism. STUDY DESIGN: An aqueous methanolic extract of Berberis orthobotrys roots was prepared and submitted to a multi-step liquid-liquid fractionation with solvents of increasing polarity. Vascular reactivity of the different fractions was assessed using porcine coronary artery rings either with or without endothelium, and in the presence or absence of specific pharmacological tools. The ability of Berberis orthobotrys extracts to affect phosphodiesterase (PDE) activity was evaluated using a radioenzymatic method and purified phosphodiesterases. RESULTS: The aqueous methanol extract induced similar relaxations in coronary artery rings with and without endothelium, and, amongst the three derived preparations, the butanol fraction (BFBO) was slightly but significantly more effective than the ethyl acetate fraction and the aqueous residue in rings without endothelium. Analysis of the butanol fraction (BFBO) by LC-ELSD-MS indicated the presence of four major isoquinoline alkaloids including berberine. BFBO significantly potentiated the relaxations induced by cyclic GMP- and cyclic AMP-dependent relaxing agonists, and inhibited contractions to KCl, CaCl2, and U46619 in endothelium denuded rings. In contrast, BFBO did not affect relaxations to endothelium-dependent vasodilators. BFBO concentration-dependently inhibited the cyclic GMP-hydrolyzing activity of basal PDE1, calmodulin-activated PDE1 and PDE5, and of cyclic AMP-hydrolyzing activity of PDE3 and PDE4 with IC50 values ranging from 40 to 130µg/ml. CONCLUSION: The butanol fraction of the aqueous methanol extract of Berberis orthobotrys roots induced pronounced endothelium-independent relaxations and inhibited contractile responses by acting directly at the vascular smooth muscle in the coronary artery. Moreover, BFBO potentiated relaxations induced by both cyclic GMP- and cyclic AMP-dependent vasodilators most likely due to its ability to inhibit several vascular PDEs, and in particular PDE4 and PDE5.
Sujet(s)
Berberis/composition chimique , Vaisseaux coronaires/effets des médicaments et des substances chimiques , Endothélium vasculaire/effets des médicaments et des substances chimiques , Relâchement musculaire/effets des médicaments et des substances chimiques , Inhibiteurs de la phosphodiestérase/pharmacologie , Extraits de plantes/pharmacologie , Racines de plante/composition chimique , Acétates , Animaux , Butanols , Techniques in vitro , Muscles lisses vasculaires/effets des médicaments et des substances chimiques , Solvants , Suidae , EauRÉSUMÉ
Aging is associated with a markedly increased incidence of cardiovascular diseases due, in part, to the development of vascular endothelial dysfunction. The present study has evaluated whether the Crataegus special extract WS(®)1442 prevents the development of aging-related endothelial dysfunction in rats, and, if so, to determine the underlying mechanisms. Wistar rats received either a control diet or the same diet containing 100 or 300 mg/kg/day of WS(®)1442 from week 25 until week 65. Vascular reactivity was assessed in mesenteric artery rings using organ chambers, oxidative stress by dihydroethidine staining and cyclooxygenase-1 (COX-1) and -2 (COX-2) expression by immunohistochemistry. Acetylcholine-induced endothelium-dependent relaxations in mesenteric artery rings were blunted in 65-week-old rats compared to 16-week-old rats. This effect was associated with a marked reduction of the endothelium-derived hyperpolarizing factor (EDHF) component whereas the nitric oxide (NO) component was not affected. Aging was also associated with the induction of endothelium-dependent contractile responses to acetylcholine. Both aging-related impairment of endothelium-dependent relaxations and the induction of endothelium-dependent contractile responses were improved by the Crataegus treatment and by COX inhibitors. An excessive vascular oxidative stress and an upregulation of COX-1 and COX-2 were observed in the mesenteric artery of old rats compared to young rats, and these effects were improved by the Crataegus treatment. In conclusion, chronic intake of Crataegus prevented aging-related endothelial dysfunction by reducing the prostanoid-mediated contractile responses, most likely by improving the increased oxidative stress and the overexpression of COX-1 and COX-2.
Sujet(s)
Vieillissement/physiologie , Endothélium vasculaire/effets des médicaments et des substances chimiques , Endothélium vasculaire/physiologie , Extraits de plantes/pharmacologie , Animaux , Facteurs biologiques/métabolisme , Dérivés du biphényle/pharmacologie , Crataegus , Cyclooxygenase 1/métabolisme , Cyclooxygenase 2/métabolisme , Inhibiteurs des cyclooxygénases/pharmacologie , Acides heptanoïques/pharmacologie , Techniques in vitro , Indométacine/pharmacologie , Mâle , Artères mésentériques/effets des médicaments et des substances chimiques , Relâchement musculaire/effets des médicaments et des substances chimiques , Monoxyde d'azote/métabolisme , Stress oxydatif , Rats , Rat Wistar , Espèces réactives de l'oxygène/métabolismeRÉSUMÉ
Inverted CCAAT box-binding protein of 90 kDa (ICBP90) is over-expressed in several types of cancer, including breast, prostate and lung cancers. In search for proteins that interact with the set and ring-associated (SRA) domain of ICBP90, we used the two-hybrid system and screened a placental cDNA library. Several clones coding for a new domain of DNMT1 were found. The interaction, between the ICBP90 SRA domain and the DNMT1 domain, has been confirmed with purified proteins by glutathione-S-transferase pull-down experiments. We checked whether ICBP90 and DNMT1 are present in the same macro-molecular complexes in Jurkat cells and immortalized human vascular smooth muscle cells (HVTs-SM1). Co-immunoprecipitation experiments showed that ICBP90 and DNMT1 are present in the same molecular complex, which was further confirmed by co-localization experiments as assessed by immunocytochemistry. Downregulation of ICBP90 and DNMT1 decreased VEGF gene expression, a major pro-angiogenic factor, whereas those of p16(INK4A) gene and RB1 gene were significantly enhanced. Together, these results indicate that DNMT1 and ICBP90 are involved in VEGF gene expression, possibly via an interaction of the SRA domain of ICBP90 with a novel domain of DNMT1 and an upregulation of p16(INK4A). They further suggest a new role of ICBP90 in the relationship between histone ubiquitination and DNA methylation in the context of tumoral angiogenesis and tumour suppressor genes silencing.
Sujet(s)
Protéines liant les séquences stimulatrices de type CCAAT/métabolisme , Protéines liant les séquences stimulatrices de type CCAAT/physiologie , DNA (cytosine-5-)-methyltransferase/métabolisme , DNA (cytosine-5-)-methyltransferase/physiologie , Régulation de l'expression des gènes , Facteur de croissance endothéliale vasculaire de type A/génétique , Protéines liant les séquences stimulatrices de type CCAAT/composition chimique , Cellules cultivées , DNA (Cytosine-5-)-methyltransferase 1 , Gènes suppresseurs de tumeur , Histone/métabolisme , Humains , Immunoprécipitation , Cellules Jurkat , Modèles biologiques , Néovascularisation pathologique/génétique , Liaison aux protéines/physiologie , Structure tertiaire des protéines , Interférence par ARN , Ubiquitin-protein ligases , Ubiquitination/génétiqueRÉSUMÉ
INTRODUCTION: Vascular endothelium possesses biological properties that are involved in important physiological functions such vascular permeability, vascular tone regulation and angiogenesis. The difficulty of culture and long-term maintenance of sufficient amount of normal endothelial cells has proven to be the limitation for the understanding of the biological function of the endothelium. Therefore, the aim of this study was to culture and characterize the porcine coronary endothelial cells. MATERIAL AND METHODS: The endothelial cells were isolated by collagenase treatment and cultured in culture dishes coated with collagen, prepared from rat tail, containing medium RPMI1640/M199 and 15% fetal calf serum supplemented with antibiotics and fungizon. The cells were maintained to grown at 37 degrees C. The medium was changed one day after and then every two day. The cells were incubated with Dil-labeled-acetylated-LDL for determination of acetylated-LDL uptake. Confluence cultures of cells were examined by phase-contrast and confocal microscopy. RESULTS: After a day of culture, the endothelial cells adhere to the collagen and began to grow. While multiplying themselves, they colonize little by little the body of the surface of culture to form to confluence a monolayer of flat cells relatively homogenous. To confluence, the proliferation of the endothelial cells is inhibited by the contact and the cells present a polygonal aspect. Our results show that all the cultivated cells were strongly positive for acetylated-LDL markers. The endothelial cells, cultivated until the second passage corresponding to the second culture of the primary cultures, continued to present a good fluorescence. CONCLUSION: Porcine coronary endothelial cells represent a useful in vitro model to study biological and physiopathological properties of vascular endothelium.
Sujet(s)
Vaisseaux coronaires/cytologie , Cellules endothéliales/cytologie , Endothélium vasculaire/cytologie , Animaux , Techniques de culture cellulaire , Cellules cultivées , Collagène , Milieux de culture , Microscopie confocale , Microscopie de contraste de phase , Modèles animaux , Rats , Suidae , Facteurs tempsRÉSUMÉ
Açai (Euterpe oleracea Mart.) a fruit from the Amazon region, largely consumed in Brazil is rich in polyphenols. Experiments were undertaken to determine whether hydro-alcoholic extract obtained from stone of açaí induces a vasodilator effect in the rat mesenteric vascular bed precontracted with norepinephrine (NE) and, if so, to elucidate the underlying mechanism. Açai stone extract (ASE, 0.3-100 microg) induced a long-lasting endothelium-dependent vasodilation that was significantly reduced by N(G)-nitro-l-arginine methyl ester (l-NAME) and (1)H-[1,2,3] oxadiazolo [4,4-a] quinoxalin-l-one (ODQ) and abolished by KCl (45 mM) plus l-NAME. In vessels precontrated with NE and KCl (45 mM) or treated with K(Ca)(+2) channel blockers (charybdotoxin plus apamin), the effect of ASE was significantly reduced. However this effect is not affect by indomethacin, glybenclamide and 4-aminopiridine. Atropine, pyrilamine, yohimbine and HOE 140 significantly reduced the vasodilator effect of acetylcholine, histamine, clonidine and bradykinin, respectively, but did not change the vasodilator effect of ASE. In cultured endothelial cells ASE (100 microg/mL) induced the formation of NO that was reduced by N(G)-nitro-l-arginine (l-NA, 100 microM). The present study demonstrates that the vasodilator effect of ASE is dependent on activation of NO-cGMP pathway and may also involve endothelium-derived hyperpolarizing factor (EDHF) release. The vasodilator effect suggest a possibility to use ASE as a medicinal plant, in the treatment of cardiovascular diseases.
Sujet(s)
Arecaceae , Endothélium vasculaire/effets des médicaments et des substances chimiques , Artères mésentériques/effets des médicaments et des substances chimiques , Vasodilatation/effets des médicaments et des substances chimiques , Vasodilatateurs/pharmacologie , Animaux , Arecaceae/composition chimique , Facteurs biologiques/métabolisme , Brésil , Cellules cultivées , GMP cyclique/métabolisme , Relation dose-effet des médicaments , Cellules endothéliales/effets des médicaments et des substances chimiques , Endothélium vasculaire/métabolisme , Facteurs de relaxation dépendants de l'endothélium/métabolisme , Fruit , Guanylate cyclase/métabolisme , Mâle , Mésentère/vascularisation , Monoxyde d'azote/métabolisme , Extraits de plantes/isolement et purification , Extraits de plantes/pharmacologie , Plantes médicinales , Canaux potassiques/effets des médicaments et des substances chimiques , Rats , Rat Wistar , Facteurs temps , Vasoconstricteurs/pharmacologie , Vasodilatateurs/isolement et purificationRÉSUMÉ
BACKGROUND AND PURPOSE: Red wine polyphenols (RWPs) inhibit the expression of vascular endothelial growth factor (VEGF), a major pro-angiogenic and pro-atherosclerotic factor, in vascular smooth muscle cells (VSMCs). The aim of this study was to identify which red wine polyphenols were inhibitory and to determine the mechanism underlying the inhibitory effects. EXPERIMENTAL APPROACH: Release of VEGF stimulated by platelet derived growth factor(AB) (PDGF(AB)), from human aortic VSMCs was measured by immunoassay and phosphorylation of kinases by Western blot analysis. The direct antioxidant properties of polyphenols were determined by electron paramagnetic resonance and the cellular formation of reactive oxygen species (ROS) by dichlorofluorescein. KEY RESULTS: The inhibitory effect of RWPs on PDGF(AB)-induced release of VEGF was mimicked by delphinidin but not by quercetin, catechins, resveratrol, gallic acid or caffeic acid. In the anthocyanin class, not only delphinidin but also cyanidin prevented VEGF release whereas malvidin and peonidin were without effect. RWPs, delphinidin and cyanidin directly scavenged ROS and prevented the PDGF(AB)-induced formation of ROS in VSMCs. Malvidin and peonidin did not scavenge ROS but prevented the cellular formation of ROS. Although the p38 MAPK, ERK1/2 and JNK pathways have been involved in the PDGF(AB)-induced expression of VEGF, in our experiments, only phosphorylation of p38 MAPK and JNK was inhibited by RWPs, delphinidin and cyanidin. CONCLUSIONS AND IMPLICATIONS: Anthocyanins presenting a hydroxyl residue at position 3' are able to inhibit PDGF(AB)-induced VEGF expression by preventing activation of p38 MAPK and JNK in VSMCs.
Sujet(s)
Anthocyanes/pharmacologie , JNK Mitogen-Activated Protein Kinases/antagonistes et inhibiteurs , Muscles lisses vasculaires/métabolisme , Facteur de croissance dérivé des plaquettes/antagonistes et inhibiteurs , Facteur de croissance endothéliale vasculaire de type A/métabolisme , p38 Mitogen-Activated Protein Kinases/antagonistes et inhibiteurs , Antioxydants/pharmacologie , Cellules cultivées , Activation enzymatique/effets des médicaments et des substances chimiques , Extracellular Signal-Regulated MAP Kinases/physiologie , Humains , JNK Mitogen-Activated Protein Kinases/physiologie , Système de signalisation des MAP kinases/effets des médicaments et des substances chimiques , p38 Mitogen-Activated Protein Kinases/physiologieRÉSUMÉ
BACKGROUND: The use of sex steroids in oral contraception or hormonal replacement therapy is associated with an increased risk of cardiovascular thromboembolic complications. Although both the estrogen and the progestin components have been involved, the underlying mechanisms responsible are unclear. METHODS AND RESULTS: This study examined whether sex steroids promote hemostasis indirectly by increasing the procoagulant activity of blood vessels. Treatment of vascular smooth muscle cells with several progestins (progesterone, 3-keto-desogestrel, gestodene, and medroxyprogesterone acetate) upregulated proteolytically activatable thrombin receptor (PAR-1) expression, resulting in a potentiated thrombin-induced tissue factor expression and surface procoagulant activity. In contrast, neither the progestins levonorgestrel, norethisterone, and norgestimate nor the synthetic estrogen 17alpha-ethinylestradiol had such effects. The effect of the stimulatory progestins, which induce glucocorticoid-like effects in several cell systems, was mimicked by dexamethasone and inhibited by the progesterone and glucocorticoid receptor antagonist RU-38486. In addition, long-term administration of progesterone, 3-keto-desogestrel, or medroxyprogesterone acetate to ovariectomized rats increased PAR-1 protein level in the arterial wall, resulting in an increased responsiveness of isolated aortic rings to thrombin. CONCLUSIONS: These data demonstrate that several progestins markedly potentiate the vascular procoagulant effects of thrombin by increasing the availability of membrane thrombin receptors in the smooth muscle, an effect that is most likely due to their glucocorticoid-like activity.
Sujet(s)
Coagulation sanguine/effets des médicaments et des substances chimiques , Muscles lisses vasculaires/effets des médicaments et des substances chimiques , Progestines/pharmacologie , Récepteurs à la thrombine/effets des médicaments et des substances chimiques , Animaux , Aorte/effets des médicaments et des substances chimiques , Aorte/physiologie , Technique de Northern , Technique de Western , Cellules cultivées , Désogestrel/pharmacologie , Dexaméthasone/pharmacologie , Relation dose-effet des médicaments , Endothélium vasculaire/physiologie , Femelle , Régulation de l'expression des gènes/effets des médicaments et des substances chimiques , Humains , Techniques in vitro , Acétate de médroxyprogestérone/pharmacologie , Mifépristone/pharmacologie , Muscles lisses vasculaires/cytologie , Muscles lisses vasculaires/métabolisme , Norprégnènes/pharmacologie , Ovariectomie , Progestérone/pharmacologie , ARN messager/effets des médicaments et des substances chimiques , ARN messager/génétique , ARN messager/métabolisme , Rats , Rat Wistar , Récepteur de type PAR-1 , Récepteurs aux glucocorticoïdes/antagonistes et inhibiteurs , Récepteurs aux glucocorticoïdes/physiologie , Récepteurs à la progestérone/antagonistes et inhibiteurs , Récepteurs à la thrombine/génétique , Récepteurs à la thrombine/métabolisme , Thrombine/pharmacologie , Vasoconstriction/effets des médicaments et des substances chimiquesRÉSUMÉ
Vascular endothelial growth factor (VEGF) has been implicated in the reendothelialization of the vascular wall after balloon injury. This study investigated whether thrombin, which is formed during activation of the coagulation cascade at sites of vascular injury, upregulates VEGF expression in vascular smooth muscle cells (VSMCs). VEGF expression was assessed in native and cultured VSMCs by Northern blot analysis and reverse transcription-polymerase chain reaction and the release of VEGF protein by immunoassay. alpha-Thrombin time- and concentration-dependently increased VEGF mRNA levels, mainly that mRNA coding for the soluble splice variant VEGF(164/165), and stimulated the release of VEGF protein. These effects required the proteolytic activity of thrombin and were mimicked by a thrombin receptor activating-peptide. Upregulation of VEGF expression was also induced by conditioned medium from alpha-thrombin-stimulated VSMCs. Both the early and the delayed alpha-thrombin-induced VEGF expressions were attenuated by antioxidants and by diphenyleneiodonium. alpha-Thrombin-induced VEGF release was significantly reduced by a platelet-derived growth factor (PDGF)-, a transforming growth factor (TGF)-beta-, and a basic fibroblast growth factor (bFGF)-neutralizing antibody. Thrombin caused a redox-sensitive upregulation of expression of VEGF in VSMCs through a direct and an indirect effect, which was dependent on the endogenous formation of PDGF, TGF-beta, and bFGF. Upregulation of VEGF expression may represent an important mechanism by which the coagulation cascade contributes to the regeneration of the endothelial lining at sites of balloon injury.
Sujet(s)
Facteurs de croissance endothéliale/biosynthèse , Lymphokines/biosynthèse , Muscles lisses vasculaires/métabolisme , Espèces réactives de l'oxygène/physiologie , Thrombine/pharmacologie , Acétylcystéine/pharmacologie , Angioplastie par ballonnet/effets indésirables , Animaux , Antioxydants/pharmacologie , Artériopathies oblitérantes/étiologie , Acide ascorbique/pharmacologie , Cellules cultivées , Facteurs de croissance endothéliale/génétique , Facteur de croissance fibroblastique de type 2/biosynthèse , Humains , Cinétique , Lymphokines/génétique , Mâle , Muscles lisses vasculaires/effets des médicaments et des substances chimiques , Facteur de croissance dérivé des plaquettes/biosynthèse , ARN messager/biosynthèse , Rats , Rat Wistar , Activation de la transcription , Facteur de croissance transformant bêta/biosynthèse , Facteur de croissance endothéliale vasculaire de type A , Facteurs de croissance endothéliale vasculaireRÉSUMÉ
The heterodimeric transcription factor hypoxia-inducible factor-1 (HIF-1) is activated under hypoxic conditions, resulting in the upregulation of its target genes plasminogen activator inhibitor-1 (PAI-1) and vascular endothelial growth factor (VEGF). PAI-1 and VEGF are also induced in response to vascular injury, which is characterized by the activation of platelets and the coagulation cascade as well as the generation of reactive oxygen species (ROS). However, it is not known whether HIF-1 is also stimulated by thrombotic factors. We investigated the role of thrombin, platelet-associated growth factors, and ROS derived from the p22(phox)-containing NADPH oxidase in the activation of HIF-1 and the induction of its target genes PAI-1 and VEGF in human vascular smooth muscle cells (VSMCs). Thrombin, platelet-derived growth factor-AB (PDGF-AB), and transforming growth factor-beta(1) (TGF-beta(1)) upregulated HIF-1alpha protein in cultured and native VSMCs. This response was accompanied by nuclear accumulation of HIF-1alpha as well as by increased HIF-1 DNA-binding and reporter gene activity. The thrombin-induced expression of HIF-1alpha, PAI-1, and VEGF was attenuated by antioxidant treatment as well as by transfection of p22(phox) antisense oligonucleotides. Inhibition of p38 mitogen-activated protein kinase and phosphatidylinositol-3-kinase significantly decreased thrombin-induced HIF-1alpha, PAI-1, and VEGF expression. These findings demonstrate that the HIF-1 signaling pathway can be stimulated by thrombin and platelet-associated growth factors and that a redox-sensitive cascade activated by ROS derived from the p22(phox)-containing NADPH oxidase is crucially involved in this response.
Sujet(s)
Protéines de liaison à l'ADN/métabolisme , Protéines de transport membranaire , Muscles lisses vasculaires/métabolisme , NADPH dehydrogenase/physiologie , NADPH oxidase/physiologie , Protéines nucléaires/métabolisme , Phosphoprotéines/physiologie , Transduction du signal , Thrombine/pharmacologie , Facteurs de transcription , Antioxydants/pharmacologie , Cellules cultivées , Protéines de liaison à l'ADN/physiologie , Facteurs de croissance endothéliale/biosynthèse , Facteurs de croissance endothéliale/génétique , Humains , Facteur-1 induit par l'hypoxie , Sous-unité alpha du facteur-1 induit par l'hypoxie , Lymphokines/biosynthèse , Lymphokines/génétique , Mitogen-Activated Protein Kinases/physiologie , Muscles lisses vasculaires/effets des médicaments et des substances chimiques , Muscles lisses vasculaires/enzymologie , Protéines nucléaires/physiologie , Phosphatidylinositol 3-kinases/physiologie , Inhibiteur-1 d'activateur du plasminogène/biosynthèse , Inhibiteur-1 d'activateur du plasminogène/génétique , Facteur de croissance dérivé des plaquettes/pharmacologie , ARN messager/biosynthèse , Espèces réactives de l'oxygène/physiologie , Activation de la transcription , Facteur de croissance endothéliale vasculaire de type A , Facteurs de croissance endothéliale vasculaire , p38 Mitogen-Activated Protein KinasesRÉSUMÉ
Vascular injury after balloon angioplasty results in the rapid activation of platelets leading to the release of growth factors and vasoactive substances. In addition, up-regulation of tissue factor (TF) and an increased production of reactive oxygen species (ROS) have been detected at sites of vascular injury. We investigated whether platelet-derived products (PDP) released from activated human platelets increase ROS production, resulting in the induction of TF expression in vascular smooth muscle cells (SMC). PDP induced a time- and concentration-dependent increase in ROS generation in cultured SMC that was mediated mainly by PDGF-AB and TGF-beta1 and impaired by the flavin inhibitor diphenylene iodonium. Increased ROS formation was associated with enhanced mRNA levels of the small NAD(P)H oxidase subunit p22phox or its smooth muscle isoform. Transient transfection with a p22phox antisense vector decreased PDP-induced ROS generation. PDP up-regulated TF mRNA expression, which was redox sensitive and reduced by transfection of the p22phox antisense vector. In addition, PDP-stimulated reporter gene activity of two TF promoter constructs was decreased by coexpression of the p22phox antisense vector. These results indicate that activated platelets up-regulate TF expression and that this response involves ROS generation and a p22phox-containing NAD(P)H oxidase in SMC.
Sujet(s)
Plaquettes/métabolisme , Protéines de transport membranaire , Muscles lisses vasculaires/métabolisme , NADPH dehydrogenase/métabolisme , Stress oxydatif , Phosphoprotéines/métabolisme , Activation plaquettaire/physiologie , Thromboplastine/métabolisme , Animaux , Cellules cultivées , Cytochromes de type c/métabolisme , Relation dose-effet des médicaments , Régulation de l'expression des gènes codant pour des enzymes/effets des médicaments et des substances chimiques , Humains , Mâle , Muscles lisses vasculaires/cytologie , Muscles lisses vasculaires/effets des médicaments et des substances chimiques , Muscles lisses vasculaires/enzymologie , NADPH dehydrogenase/génétique , NADPH oxidase , Oligonucléotides antisens/génétique , Oligonucléotides antisens/métabolisme , Oxydoréduction/effets des médicaments et des substances chimiques , Stress oxydatif/effets des médicaments et des substances chimiques , Phosphoprotéines/génétique , Facteur de croissance dérivé des plaquettes/métabolisme , Facteur de croissance dérivé des plaquettes/pharmacologie , ARN messager/génétique , ARN messager/métabolisme , Rats , Rat Wistar , Espèces réactives de l'oxygène/métabolisme , Transduction du signal/effets des médicaments et des substances chimiques , Thromboplastine/génétique , Facteurs temps , Transfection , Facteur de croissance transformant bêta/métabolisme , Facteur de croissance transformant bêta/pharmacologie , Régulation positive/effets des médicaments et des substances chimiquesRÉSUMÉ
The progestin and oestrogen component of oral contraceptives have been involved in the development of venous thromboembolic events in women. In the present study we determined the vasoactive effects of sex steroids used in oral contraceptives in isolated preconstricted rabbit jugular veins in the presence of diclofenac and examined the underlying mechanisms. The natural hormone progesterone, the synthetic progestins levonorgestrel, 3-keto-desogestrel, gestodene and chlormadinone acetate, and the synthetic estrogen 17 alpha-ethinyloestradiol induced concentration-dependent relaxations of endothelium-intact veins constricted with U46619. Levonorgestrel also inhibited constrictions evoked by either a high potassium (K(+)) solution or phorbol myristate acetate (PMA) in the absence and presence of extracellular calcium (Ca(2+)). In addition, levonorgestrel depressed contractions evoked by Ca(2+) and reduced (45)Ca(2+) influx in depolarized veins. Relaxations to levonorgestrel in U46619-constricted veins were neither affected by the presence of the endothelium nor by the inhibitor of soluble guanylyl cyclase, NS2028, but were significantly improved either by the selective cyclic AMP phosphodiesterase inhibitor rolipram or in the absence of diclofenac, and decreased by the protein kinase A inhibitor, Rp-8-CPT-cAMPS. Rolipram also potentiated relaxations to levonorgestrel in PMA-constricted veins in the presence, but not in the absence of extracellular Ca(2+). Levonorgestrel increased levels of cyclic AMP and inhibited PMA-induced activation of protein kinase C in veins. These findings indicate that levonorgestrel caused endothelium-independent relaxations of jugular veins via inhibition of Ca(2+) entry and of protein kinase C activation. In addition, the cyclic AMP effector pathway contributes to the levonorgestrel-induced relaxation possibly by depressing Ca(2+) entry.
Sujet(s)
Calcium/métabolisme , GMP cyclique/analogues et dérivés , Endothélium vasculaire/physiologie , Veines jugulaires/effets des médicaments et des substances chimiques , Lévonorgestrel/pharmacologie , Congénères de la progestérone/pharmacologie , Protéine kinase C/antagonistes et inhibiteurs , Vasodilatation/effets des médicaments et des substances chimiques , Acide 15-hydroxy-11alpha,9alpha-(époxyméthano)prosta-5,13-diénoïque/pharmacologie , Animaux , Calcium/pharmacologie , Chlorure de calcium/pharmacologie , Chlormadinone/pharmacologie , AMP cyclique/métabolisme , AMP cyclique/physiologie , GMP cyclique/pharmacologie , Désogestrel/pharmacologie , Relation dose-effet des médicaments , Éthinyloestradiol/pharmacologie , Techniques in vitro , Veines jugulaires/métabolisme , Veines jugulaires/physiologie , Mâle , Norprégnènes/pharmacologie , Chlorure de potassium/pharmacologie , Lapins , Rolipram/pharmacologie , 12-Myristate-13-acétate de phorbol/pharmacologie , Thionucléotides/pharmacologieRÉSUMÉ
Insulin has been suggested to prevent the induction of nitric oxide synthase (NOS) in vitro in arterial smooth muscle, but whether such a mechanism is operative in vivo is not known. Therefore, we evaluated the sensitivity of smooth muscle NOS to induction by interleukin-1beta (IL-1beta) in aortic rings of lean and obese Zucker rats, a model of experimental hyperinsulinaemia. In order to modulate the insulin and glucose balance of the rats, a 22-week-long treadmill exercise was included in the study. The training attenuated weight gain and reduced blood glucose in the obese and lean rats, whereas the abnormally high plasma insulin of the obese rats remained unaffected. A 6-h incubation of aortic rings with IL-1beta (10 ng/ml) increased cyclic GMP in smooth muscle by approximately threefold in all groups, and this effect was prevented by methylene blue. The contractile sensitivity of endothelium-denuded aortic rings to phenylephrine was reduced by incubation with IL-1beta (1 ng/ml and 10 ng/ml) in the exercised obese and lean rats, whereas no significant change was observed in the sedentary groups. The aortic maximal contractile force induced by phenylephrine was reduced in sedentary and exercised obese rats by incubation with IL-1beta, while no change was detected in the lean rats. The aortic relaxation to exogenous L-arginine was augmented by IL-1beta in all groups, while the relaxation sensitivity to L-arginine after induction by IL-1beta was enhanced by exercise in the obese but not in the lean rats. Finally, the relaxation to nitroprusside was not significantly affected by IL-1beta in any of the study groups. In conclusion, since maximal contractile force generation to phenylephrine was reduced by IL-1beta in the obese but not in the lean rats, the sensitivity of NOS to induction by IL-1beta was higher in arterial smooth muscle of the obese than the lean Zucker rats. Thus, this model of hyperinsulinaemia was not associated with reduced sensitivity of smooth muscle NOS to induction by IL-1beta. Regular exercise did not change plasma insulin concentrations, but it enhanced the action of insulin in both strains as reflected by reduced blood glucose, and increased the sensitivity of smooth muscle NOS to induction by IL-1beta.
Sujet(s)
Hyperinsulinisme/métabolisme , Interleukine-1/pharmacologie , Monoxyde d'azote/biosynthèse , Animaux , Aorte/effets des médicaments et des substances chimiques , Aorte/physiopathologie , Poids , Hyperinsulinisme/physiopathologie , Techniques in vitro , Mâle , Contraction musculaire/effets des médicaments et des substances chimiques , Relâchement musculaire/effets des médicaments et des substances chimiques , Muscles lisses vasculaires/effets des médicaments et des substances chimiques , Muscles lisses vasculaires/physiopathologie , Myocarde/anatomopathologie , Taille d'organe , Conditionnement physique d'animal , Rats , Rat ZuckerRÉSUMÉ
BACKGROUND: Vascular endothelial growth factor (VEGF), an endothelial mitogen and chemoattractant, has been implicated in the recovery of the endothelium after balloon injury. The increased expression of VEGF in vascular smooth muscle cells (SMC) at sites of injury suggests that this cell type may be a major cellular source of VEGF. This study examined whether aggregating platelets stimulate VEGF expression in cultured SMC. METHODS AND RESULTS: ++VEGF expression in SMC was assessed by Northern blot analysis and by reverse transcription followed by polymerase chain reaction and the release of VEGF by Western blot analysis and immunoassay. Platelet-derived products (PDP) released by aggregating human platelets time-dependently and concentration-dependently enhanced VEGF mRNA levels, mainly that coding for the soluble splice variant VEGF(165/164), and stimulated the release of VEGF protein. These effects were potentiated by transient acidification of PDP, which release bioactive transforming growth factor (TGF)-beta(1), and mimicked by platelet-derived growth factor (PDGF)(AB) and TGF-beta(1) in a synergistic manner. Both a TGF-beta-neutralizing antibody and a PDGF-neutralizing antibody significantly attenuated the effect of acidified PDP on VEGF production. CONCLUSIONS: Aggregating human platelets induce VEGF mRNA expression in cultured SMC and the subsequent release of VEGF protein. This effect can be attributed to a supra-additive action of PDGF(AB) and TGF-beta(1) and may represent a novel mechanism by which platelets contribute to the recovery of the endothelial lining at sites of balloon-injured arteries.
Sujet(s)
Protéines de transport/physiologie , Facteurs de croissance endothéliale/biosynthèse , Protéines et peptides de signalisation intracellulaire , Muscles lisses vasculaires/métabolisme , Agrégation plaquettaire/physiologie , Facteur de croissance dérivé des plaquettes/physiologie , Angioplastie par ballonnet/effets indésirables , Technique de Northern , Technique de Western , Cellules cultivées , Facteurs de croissance endothéliale/génétique , Endothélium vasculaire/anatomopathologie , Humains , Protéines de liaison au TGF-bêta latent , ARN messager/analyse , Transcription génétiqueRÉSUMÉ
The free radical nitric oxide (NO) has emerged as an important signal effector molecule that controls critical functions in the mammalian cardiovascular system in both healthy and diseased states. In normal blood vessels, NO is synthesized from L-arginine by a constitutively expressed NO synthase (NOS III) in endothelial cells. The endothelial formation of NO can be increased by both pharmacological and physiological agonists (e.g. bradykinin) and this effect is dependent on the interaction of calcium/calmodulin with NOS III. Recent observations suggest that NO is a pivotal mediator of insulin-like growth factor (IGF)-I-induced vasodilatation in humans and experimental animals. Administration of IGF-I in the human brachial artery increased blood flow in the forearm, an effect which was abolished by N(G)-monomethyl-L-arginine (L-NMMA), an inhibitor of NOS. Inhibitors of NOS also prevented the IGF-I-induced renal vasodilatation in anesthetized rats and in in vitro blood-perfused preparations of rat juxtamedullary nephrons. In addition, IGF-I caused concentration-dependent relaxation of precontracted isolated arteries that required the presence of a functional endothelium, and this effect was abolished by L-NMMA. Moreover, the rapid formation of NO in response to IGF-I is detected in cultured endothelial cells by an amperometric NO sensor. The signalling of NO formation is independent of changes in intracellular Ca2+ and involves tyrosine kinase and phosphatidylinositol-3-kinase. At sites of vascular injury, proinflammatory mediators can stimulate the expression of an inducible NOS (NOS II) that generates large amounts of NO for prolonged periods of time. IGF-I has been shown to inhibit the interleukin-1beta-induced formation of NO in cultured vascular smooth muscle cells by preventing the induction of NOS II. In conclusion, IGF-I may be an important regulator of vascular tone in part by modulating the formation of NO by NOS III and NOS II in the vascular wall.
Sujet(s)
Endothélium vasculaire/effets des médicaments et des substances chimiques , Facteur de croissance IGF-I/pharmacologie , Muscles lisses vasculaires/effets des médicaments et des substances chimiques , Nitric oxide synthase/métabolisme , Monoxyde d'azote/biosynthèse , Animaux , Endothélium vasculaire/cytologie , Endothélium vasculaire/métabolisme , Humains , Muscles lisses vasculaires/cytologie , Muscles lisses vasculaires/métabolisme , Nitric oxide synthase type IIRÉSUMÉ
OBJECTIVE: Vascular endothelial growth factor (VEGF), secreted by vascular cells and a variety of tumour cells, is a potent angiogenic factor. Since nitric oxide (NO) seems to play a key role in the VEGF-induced proliferation of endothelial cells, the aim of the present study was to determine whether VEGF stimulates endothelial NO synthase (eNOS) expression and hence results in a maintained increase in NO formation. METHODS: Experiments were performed using cultured human umbilical vein endothelial cells (HUVEC) and isolated rat aortic rings. eNOS expression was assessed by Western blotting and RT-PCR analysis. RESULTS: Exposure of either confluent HUVEC or rat aortic rings to VEGF165 significantly increased eNOS mRNA and protein levels. This stimulatory effect of VEGF165 on eNOS expression was associated with an elevation in the basal production of cGMP in HUVEC, and with a leftward shift of the concentration-relaxation curve to acetylcholine in aortic rings. The VEGF-induced increase in eNOS mRNA levels was abolished by tyrosine kinase inhibitors suggesting involvement of a tyrosine kinase-dependent pathway. Since eNOS mRNA levels remained elevated in VEGF-treated cells in the presence of actinomycin D. it is likely that the VEGF-induced up-regulation of eNOS expression may be a consequence of a post-transcriptional effect on eNOS mRNA stability. CONCLUSION: The results demonstrate that VEGF enhances the expression of eNOS in native and cultured endothelial cells, an effect which may be important in the process of VEGF-induced angiogenesis.